(Q44815058)

6 December 2017

Challenges in the evaluation and licensing of new pneumococcal vaccines, 7-8 July 2008, Ottawa, Canada (English)

1 reference

6 December 2017

0 references

1 reference

I Feavers

1

1 reference

6 December 2017

I Knezevic

2

1 reference

6 December 2017

M Powell

3

1 reference

6 December 2017

E Griffiths

4

1 reference

6 December 2017

WHO Consultation on Serological Criteria for Evaluation and Licensing of New Pneumococcal Vaccines

5

1 reference

6 December 2017

language of work or name

English

0 references

publication date

17 April 2009

1 reference

6 December 2017

1 reference

6 December 2017

27

1 reference

6 December 2017

28

1 reference

6 December 2017

3681-3688

1 reference

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.087

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.087

Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.087

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.087

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.087

Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.087

Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.087

Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.087

Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.087

Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.087

10.1016/J.VACCINE.2009.03.087

7 January 2021

Identifiers

DOI

1 reference

6 December 2017

1 reference